{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:12:41Z","timestamp":1791871961942,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T00:00:00Z","timestamp":1620604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","award":["TECH-13-059"],"award-info":[{"award-number":["TECH-13-059"]}],"id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R34-EY029308"],"award-info":[{"award-number":["R34-EY029308"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["K23-EY022947-01A1"],"award-info":[{"award-number":["K23-EY022947-01A1"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002806","name":"Carl Zeiss Meditec AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.oret.2021.02.012","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T02:36:44Z","timestamp":1614307004000},"page":"1204-1213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Longitudinal Assessment of Ellipsoid Zone Integrity, Subretinal Hyperreflective Material, and Subretinal Pigment Epithelium Disease in Neovascular Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"5","author":[{"given":"Justis P.","family":"Ehlers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2679-2216","authenticated-orcid":false,"given":"Robert","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter K.","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Heier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Reese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuy K.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3403-7429","authenticated-orcid":false,"given":"Leina","family":"Lunasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0987-2916","authenticated-orcid":false,"given":"Ming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil K.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2021.02.012_bib1","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/bjophthalmol-2014-305702","article-title":"Guidelines for the management of neovascular age-related macular degeneration by the European Society of Retina Specialists (EURETINA)","volume":"98","author":"Schmidt-Erfurth","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"2-a Suppl","key":"10.1016\/j.oret.2021.02.012_bib2","first-page":"S3","article-title":"Optimizing anti-VEGF treatment outcomes for patients with neovascular age-related macular degeneration","volume":"24","author":"Wykoff","year":"2018","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.oret.2021.02.012_bib3","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration","volume":"355","author":"Brown","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.oret.2021.02.012_bib4","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1097\/IAE.0000000000002717","article-title":"Topographic analysis of photoreceptor loss correlated with disease morphology in neovascular age-related macular degeneration","volume":"40","author":"Riedl","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.oret.2021.02.012_bib5","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/IAE.0000000000000877","article-title":"Correlation of visual acuity with fibrotic scar location in treated neovascular age-related macular degeneration eyes","volume":"36","author":"Ryu","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.oret.2021.02.012_bib6","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.ophtha.2015.05.042","article-title":"Subretinal hyperreflective material in the Comparison of Age-Related Macular Degeneration Treatments Trials","volume":"122","author":"Willoughby","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2021.02.012_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ophtha.2019.04.017","article-title":"HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration","volume":"127","author":"Dugel","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2021.02.012_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ajo.2018.04.007","article-title":"Automated segmentation of lesions including subretinal hyperreflective material in neovascular age-related macular degeneration","volume":"191","author":"Lee","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2021.02.012_bib9","doi-asserted-by":"crossref","first-page":"19413","DOI":"10.1364\/OE.18.019413","article-title":"Automatic segmentation of seven retinal layers in SDOCT images congruent with expert manual segmentation","volume":"18","author":"Chiu","year":"2010","journal-title":"Opt Express"},{"key":"10.1016\/j.oret.2021.02.012_bib10","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1167\/iovs.14-15256","article-title":"RefMoB, a reflectivity feature model-based automated method for measuring four outer retinal hyperreflective bands in optical coherence tomography","volume":"56","author":"Ross","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2021.02.012_bib11","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1167\/iovs.14-16344","article-title":"Visual prognosis of eyes recovering from macular hole surgery through automated quantitative analysis of spectral-domain optical coherence tomography (SD-OCT) scans","volume":"56","author":"de Sisternes","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2021.02.012_bib12","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1364\/BOE.9.002681","article-title":"Deep longitudinal transfer learning-based automatic segmentation of photoreceptor ellipsoid zone defects on optical coherence tomography images of macular telangiectasia type 2","volume":"9","author":"Loo","year":"2018","journal-title":"Biomed Opt Express"},{"key":"10.1016\/j.oret.2021.02.012_bib13","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.oret.2019.06.010","article-title":"Higher-order assessment of OCT in diabetic macular edema from the VISTA study: ellipsoid zone dynamics and the retinal fluid index","volume":"3","author":"Ehlers","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2021.02.012_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/bjophthalmol-2015-307105","article-title":"Volumetric ellipsoid zone mapping for enhanced visualisation of outer retinal integrity with optical coherence tomography","volume":"100","author":"Itoh","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2021.02.012_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/IAE.0b013e318263cedf","article-title":"Anatomical measures as predictors of visual outcomes in ranibizumab-treated eyes with neovascular age-related macular degeneration","volume":"33","author":"Brown","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.oret.2021.02.012_bib16","article-title":"The COX-2-selective antagonist (NS-398) inhibits choroidal neovascularization and subretinal fibrosis","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.oret.2021.02.012_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.07.007","article-title":"A\u00a0paradigm shift in imaging biomarkers in neovascular age-related macular degeneration","volume":"50","author":"Schmidt-Erfurth","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.oret.2021.02.012_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41598-018-36704-6","article-title":"Biomarkers of optical coherence tomography in evaluating the treatment outcomes of neovascular age-related macular degeneration: a real-world study","volume":"9","author":"Lai","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.oret.2021.02.012_bib19","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ophtha.2014.11.017","article-title":"Pigment epithelial detachment followed by retinal cystoid degeneration leads to vision loss in treatment of neovascular age-related macular degeneration","volume":"122","author":"Schmidt-Erfurth","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2021.02.012_bib20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ophtha.2013.06.024","article-title":"Appearance of regressing drusen on optical coherence tomography in age-related macular degeneration","volume":"121","author":"Querques","year":"2014","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.oret.2021.02.012_bib21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ophtha.2020.09.025","article-title":"Quantitative analysis of OCT for neovascular age-related macular degeneration using deep learning","volume":"128","author":"Moraes","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2021.02.012_bib22","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ophtha.2017.03.057","article-title":"Brolucizumab versus aflibercept in participants with neovascular age-related macular degeneration: a randomized trial","volume":"124","author":"Dugel","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2021.02.012_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1167\/iovs.12-10246","article-title":"A\u00a0novel segmentation algorithm for volumetric analysis of macular hole boundaries identified with optical coherence tomography","volume":"54","author":"Xu","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2021.02.012_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203324","article-title":"Assessment of inner and outer retinal layer metrics on the Cirrus HD-OCT platform in normal eyes","volume":"13","author":"Arepalli","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.oret.2021.02.012_bib25","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1097\/IAE.0b013e31820d3d01","article-title":"Association between foveal microstructure and visual outcome in age-related macular degeneration","volume":"31","author":"Shin","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.oret.2021.02.012_bib26","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1097\/IAE.0b013e31827b6439","article-title":"Correlation of spectral domain optical coherence tomography characteristics with visual acuity in eyes with subfoveal scarring after treatment for wet age-related macular degeneration","volume":"33","author":"El-Emam","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.oret.2021.02.012_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ajo.2009.01.017","article-title":"Association between foveal photoreceptor integrity and visual outcome in neovascular age-related macular degeneration","volume":"148","author":"Hayashi","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2021.02.012_bib28","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1167\/iovs.16-20637","article-title":"Three-dimensional analysis of morphologic changes and visual outcomes in neovascular age-related macular degeneration","volume":"58","author":"Lee","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2021.02.012_bib29","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.ophtha.2008.08.016","article-title":"Relationship between optical coherence tomography retinal parameters and visual acuity in neovascular age-related macular degeneration","volume":"115","author":"Keane","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2021.02.012_bib30","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1167\/iovs.09-4846","article-title":"Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degeneration","volume":"51","author":"Keane","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2021.02.012_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186955","article-title":"Advanced quantitative analysis of the sub-retinal pigment epithelial space in recurrent neovascular age-related macular degeneration","volume":"12","author":"Sasaki","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.oret.2021.02.012_bib32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/IAE.0b013e31827d2657","article-title":"Quantitative changes in retinal pigment epithelial detachments as a predictor for retreatment with anti-VEGF therapy","volume":"33","author":"Penha","year":"2013","journal-title":"Retina"},{"key":"10.1016\/j.oret.2021.02.012_bib33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ajo.2011.08.031","article-title":"Quantitative imaging of retinal pigment epithelial detachments using spectral-domain optical coherence tomography","volume":"153","author":"Penha","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2021.02.012_bib34","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.1167\/iovs.16-20976","article-title":"OCT angiography and ellipsoid zone mapping of macular telangiectasia type 2 from the AVATAR Study","volume":"58","author":"Runkle","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2021.02.012_bib35","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.oret.2017.11.009","article-title":"Ellipsoid zone mapping parameters in retinal venous occlusive disease with associated macular edema","volume":"2","author":"Banaee","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.oret.2021.02.012_bib36","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/IAE.0000000000000414","article-title":"Correlation between foveal interdigitation zone band defect and visual acuity after surgery for macular pseudohole","volume":"35","author":"Hirota","year":"2015","journal-title":"Retina"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246865302100066X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S246865302100066X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:29:37Z","timestamp":1762853377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S246865302100066X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S246865302100066X"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2021.02.012","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal Assessment of Ellipsoid Zone Integrity, Subretinal Hyperreflective Material, and Subretinal Pigment Epithelium Disease in Neovascular Age-Related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2021.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}]}}